Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart ...
According to new research from the University of Missouri School of Medicine, there may be a way to stave off a type of heart failure by improving the elasticity of cardiac muscles.
Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart failure with preserved ejection fraction (HFpEF) In ...
Higher baseline serum magnesium levels are linked to a higher risk for cardiac events in HFmrEF/HFpEF, while empagliflozin treatment shows a lower risk for these events in those with higher magnesium.
Type 2 diabetes physically alters heart muscle, energy use and structure, a human heart study finds, explaining why people ...
The American Heart Association (The Association) has awarded a prestigious $160,000 postdoctoral fellowship to Abhishek ...
Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart failure with preserved ejection fraction (HFpEF) ...
Polygenic background bidirectionally modifies the penetrance of pathogenic variants in hypertrophic (HCM) and dilated (DCM) ...
If someone's in heart failure, that means their heart is no longer able to function well enough to meet their body's needs. According to new research ...
The American Heart Association has awarded a prestigious $160,000 postdoctoral fellowship to Dr. Abhishek Mishra, a ...
Secondary US filings for Bayer assets cannot be relied on again to face future patent cliffs, demanding focus on early-stage ...
11d
Tenax Therapeutics: How Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing
The market underappreciates TENX's late-stage pipeline and risk-adjusted asset value; we recommend buying ahead of Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback